ABCA1 and atherosclerosis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Vascular Medicine Année : 2005

ABCA1 and atherosclerosis

S Soumian
  • Fonction : Auteur correspondant
  • PersonId : 894351

Connectez-vous pour contacter l'auteur
C Albrecht
  • Fonction : Auteur
Ah Davies
  • Fonction : Auteur
Rgj Gibbs
  • Fonction : Auteur

Résumé

ATP binding cassette transporter A1 (ABCA1) mediates the cellular efflux of phospholipids and cholesterol to lipid-poor apolipoprotein A1 (apoA1) and plays a significant role in high density lipoprotein (HDL) metabolism. ABCA1's role in the causation of Tangier disease, characterized by absent HDL and premature atherosclerosis, has implicated this transporter and its regulators liver-X-receptorγ (LXRγ) and peroxisome proliferator activated receptorγ (PPARγ) as new candidates potentially influencing the progression of atherosclerosis. In addition to lipid regulation, these genes are involved in apoptosis and inflammation, processes thought to be central to atherosclerotic plaque progression. A Medline-based review of the literature was carried out. Tangier disease and human heterozygotes with ABCA1 mutations provide good evidence that ABCA1 is a major candidate influencing atherosclerosis. Animal and in vitro experiments suggest that ABCA1 not only mediates cholesterol and phospholipid efflux, but is also involved in the regulation of apoptosis and inflammation. The complex and beneficial interactions between apoA1 and ABCA1 seem to be pivotal for cholesterol efflux. The expression of the ABCA1 is tightly regulated. Furthermore the plaque microenvironment could potentially promote ABCA1 protein degradation thus compromising cholesterol efflux. PPAR-LXR-ABCA1 interactions are integral to cholesterol homeostasis and these nuclear receptors have proven anti-inflammatory and anti-matrix metalloproteinase activity. Therapeutic manipulation of the ABCA1 transporter is feasible using PPAR and LXR agonists. PPAR agonists like glitazones and ABCA1 protein stabilization could potentially modify the clinical progression of atherosclerotic lesions.
Fichier principal
Vignette du fichier
PEER_stage2_10.1191%2F1358863x05vm593ra.pdf (463.96 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00572114 , version 1 (01-03-2011)

Identifiants

Citer

S Soumian, C Albrecht, Ah Davies, Rgj Gibbs. ABCA1 and atherosclerosis. Vascular Medicine, 2005, 10 (2), pp.109-119. ⟨10.1191/1358863x05vm593ra⟩. ⟨hal-00572114⟩

Collections

PEER
36 Consultations
267 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More